This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
HCA Healthcare (HCA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $274.57 in the latest trading session, marking a +0.12% move from the prior day.
Molina Healthcare (MOH) Closes $150M My Choice Wisconsin Buyout
by Zacks Equity Research
Molina Healthcare (MOH) completes the My Choice Wisconsin acquisition ahead of the updated scheduled time.
Here's Why Investors are Retaining Elevance (ELV) Stock Now
by Zacks Equity Research
Elevance's (ELV) focus on expanding the capabilities of the Carelon platform is likely to position the company for long-term growth.
3 Sector ETFs & Stocks to Bet on August Jobs Data
by Sanghamitra Saha
The U.S. economy added 187,000 jobs in August 2023, compared to the downwardly revised 157,000 in July and more than market expectations of 170,000.
Is HCA (HCA) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
HCA (HCA) possesses solid growth attributes, which could help it handily outperform the market.
Here's Why You Should Retain UnitedHealth Group (UNH) Stock Now
by Zacks Equity Research
Growth in membership, expanding government business, strategic acquisitions and improving operating margin poise UnitedHealth Group (UNH) well for growth.
Cigna's (CI) Unit Brings New Plan for Globally Mobile Seniors
by Zacks Equity Research
The new product from Cigna's (CI) Cigna Healthcare unit is likely to face significant demand in the global market.
Is It Worth Investing in HCA (HCA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in HCA (HCA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Community Health Systems (CYH) Down 31.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Most-Watched Stock HCA Healthcare, Inc. (HCA) Worth Betting on Now?
by Zacks Equity Research
Zacks.com users have recently been watching HCA (HCA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
3 MedTech Stocks to Bet on Potential Pause of Rate Hike by Fed
by Indrajit Bandyopadhyay
Interest rates impact the healthcare industry and medical device companies in various ways. Here we discuss three companies HCA, ALC and SEM that are likely to gain potential pause in rate hikes.
HCA Healthcare (HCA) & Google Cloud Unite to Improve Efficiency
by Zacks Equity Research
HCA Healthcare (HCA) partners with Google Cloud to improve and automate workflows.
Why Investors Are Snapping Up Tenet Healthcare (THC) Stock Now
by Zacks Equity Research
Tenet Healthcare (THC) patient volumes are likely to remain high as seniors resume elective procedures, which were delayed due to pandemic-related constraints.
Cigna (CI) Unit to Offer ACA Plans in 350 Counties in 2024
by Zacks Equity Research
Cigna (CI) plans to expand coverage in 15 counties in North Carolina and reach an additional 200,000 ACA Marketplace clients.
HCA Healthcare (HCA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $277.54 in the latest trading session, marking a +1.56% move from the prior day.
Is UnitedHealth (UNH) a Good Dividend Stock Choice for You?
by Zacks Equity Research
UnitedHealth's (UNH) strong balance sheet and cash-generating ability support its endeavors to return shareholders' funds.
UnitedHealth (UNH) Wins Medicaid Deal to Serve New Mexicans
by Zacks Equity Research
UnitedHealth (UNH) receives a contract from the New Mexico HSD, subsequent to which it can effectively serve the statewide Medicaid members.
Why Prudent Investors Are Snapping Up Ensign (ENSG) Stock Now
by Zacks Equity Research
Ensign (ENSG) expects to witness strong acquisition opportunities in the fall of this year.
Here's Why Encompass Health (EHC) Stock is a Strong Buy Now
by Zacks Equity Research
Encompass Health's (EHC) focus on boosting the number of licensed beds and hospitals will likely enhance market density and build scale.
Is HCA (HCA) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), HCA (HCA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Is Haemonetics (HAE) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Haemonetics (HAE) and HCA Healthcare (HCA) have performed compared to their sector so far this year.
Universal Health (UHS) Gains From Solid Segmental Performance
by Zacks Equity Research
Universal Health (UHS) gains from the uptrend in revenue growth, which in turn, is derived from expanding patient volumes. A credible financial position drives its expansion endeavors.
HCA Healthcare (HCA) Rises 24% in a Year: More Room to Run?
by Zacks Equity Research
HCA Healthcare (HCA) is well-poised for growth on the back of improved patient occupancy levels, effective telehealth services suite and solid cash-generating abilities.